Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

22.2%

2 terminated/withdrawn out of 9 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

3 of 6 completed trials have results

Key Signals

3 with results

Enrollment Performance

Analytics

N/A
7(100.0%)
7Total
N/A(7)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials
NCT05323448Not ApplicableCompleted

Efficacy of ARISTA-AH for Restoring Hemostasis Following Posterior Long-segment Spinal Fusion.

Role: collaborator

NCT02060630Not ApplicableCompleted

Best Endovascular vs. Best Surgical Therapy in Patients With Critical Limb Ischemia

Role: collaborator

NCT01295125Not ApplicableTerminated

Comparative Study of Biologic Mesh Versus Repair With Component Separation.

Role: collaborator

NCT00841685Not ApplicableCompleted

The Implantation Under Echography of Fiducial Markers in the Intraprostatic Lesion and Prostate

Role: collaborator

NCT01870401Not ApplicableCompleted

Lutonix DCB Versus Standard Balloon Angioplasty for Treatment of Below-The-Knee (BTK) Arteries

Role: collaborator

NCT02889744Not ApplicableUnknown

Comparison of Cerebral SctO2 Between 36℃ and 33℃ of TTM After Cardiac Arrest

Role: collaborator

NCT01411488Not ApplicableCompleted

Comparative Study Between Two Fecal Management Systems

Role: collaborator

NCT01995877Terminated

Evaluation of the Influence of Body Position on the Inferior Vena Cava (IVC) Diameter

Role: collaborator

NCT01864278Completed

Lutonix Global SFA Registry

Role: collaborator

All 9 trials loaded